Malaria among children under 10 years in 4 endemic health areas in Kisantu Health Zone: epidemiology and transmission.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
05 Jan 2023
Historique:
received: 11 04 2022
accepted: 14 12 2022
entrez: 5 1 2023
pubmed: 6 1 2023
medline: 10 1 2023
Statut: epublish

Résumé

The Democratic Republic of the Congo (DRC) is the second most malaria-affected country in the world with 21,608,681 cases reported in 2019. The Kongo Central (KC) Province has a malaria annual incidence of 163 cases/per 1000 inhabitants which are close to the national average of 153.4/1000. However, the malaria prevalence varies both between and within health zones in this province. The main objective of this study was to describe the epidemiology and transmission of malaria among children aged 0 to 10 years in the 4 highest endemic health areas in Kisantu Health Zone (HZ) of KC in DRC. A community-based cross-sectional study was conducted from October to November 2017 using multi-stage sampling. A total of 30 villages in 4 health areas in Kisantu HZ were randomly selected. The prevalence of malaria was measured using a thick blood smear (TBS) and known predictors and associated outcomes were assessed. Data are described and association determinants of malaria infection were analysed. A total of 1790 children between 0 and 10 years were included in 30 villages in 4 health areas of Kisantu HZ. The overall prevalence in the study area according to the TBS was 14.8% (95% CI: 13.8-16.6; range: 0-53). The mean sporozoite rate in the study area was 4.3% (95% CI: 2.6-6.6). The determination of kdr-west resistance alleles showed the presence of both L1014S and L1014F with 14.6% heterozygous L1014S/L1014F, 84.4% homozygous 1014F, and 1% homozygous 1014S. The risk factors associated with malaria infection were ground or wooden floors aOR: 15.8 (95% CI: 8.6-29.2), a moderate or severe underweight: 1.5 (1.1-2.3) and to be overweight: 1.9 (95% CI: 1.3-2.7). Malaria prevalence differed between villages and health areas within the same health zone. The control strategy activities must be oriented by the variety in the prevalence and transmission of malaria in different areas. The policy against malaria regarding long-lasting insecticidal nets should be based on the evidence of metabolic resistance.

Sections du résumé

BACKGROUND BACKGROUND
The Democratic Republic of the Congo (DRC) is the second most malaria-affected country in the world with 21,608,681 cases reported in 2019. The Kongo Central (KC) Province has a malaria annual incidence of 163 cases/per 1000 inhabitants which are close to the national average of 153.4/1000. However, the malaria prevalence varies both between and within health zones in this province. The main objective of this study was to describe the epidemiology and transmission of malaria among children aged 0 to 10 years in the 4 highest endemic health areas in Kisantu Health Zone (HZ) of KC in DRC.
METHODS METHODS
A community-based cross-sectional study was conducted from October to November 2017 using multi-stage sampling. A total of 30 villages in 4 health areas in Kisantu HZ were randomly selected. The prevalence of malaria was measured using a thick blood smear (TBS) and known predictors and associated outcomes were assessed. Data are described and association determinants of malaria infection were analysed.
RESULTS RESULTS
A total of 1790 children between 0 and 10 years were included in 30 villages in 4 health areas of Kisantu HZ. The overall prevalence in the study area according to the TBS was 14.8% (95% CI: 13.8-16.6; range: 0-53). The mean sporozoite rate in the study area was 4.3% (95% CI: 2.6-6.6). The determination of kdr-west resistance alleles showed the presence of both L1014S and L1014F with 14.6% heterozygous L1014S/L1014F, 84.4% homozygous 1014F, and 1% homozygous 1014S. The risk factors associated with malaria infection were ground or wooden floors aOR: 15.8 (95% CI: 8.6-29.2), a moderate or severe underweight: 1.5 (1.1-2.3) and to be overweight: 1.9 (95% CI: 1.3-2.7).
CONCLUSION CONCLUSIONS
Malaria prevalence differed between villages and health areas within the same health zone. The control strategy activities must be oriented by the variety in the prevalence and transmission of malaria in different areas. The policy against malaria regarding long-lasting insecticidal nets should be based on the evidence of metabolic resistance.

Identifiants

pubmed: 36604663
doi: 10.1186/s12936-022-04415-z
pii: 10.1186/s12936-022-04415-z
pmc: PMC9814333
doi:

Substances chimiques

Insecticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Informations de copyright

© 2023. The Author(s).

Références

Malar J. 2015 Feb 18;14:83
pubmed: 25880427
Malar J. 2018 Mar 27;17(1):129
pubmed: 29580247
Parasit Vectors. 2019 May 27;12(1):263
pubmed: 31133042
Am Sociol Rev. 1965 Aug;30:564-72
pubmed: 14325826
Exp Parasitol. 1987 Apr;63(2):166-72
pubmed: 3552712
J Infect Dis. 2018 Jan 4;217(2):320-328
pubmed: 29087484
Malar J. 2008 Apr 29;7:74
pubmed: 18445265
Malar J. 2020 May 24;19(1):189
pubmed: 32448213
PLoS One. 2013 Nov 06;8(11):e79966
pubmed: 24223209
Lancet Planet Health. 2018 Feb;2(2):e74-e82
pubmed: 29457150
Malar J. 2014 Mar 21;13:111
pubmed: 24656206
BMC Med Res Methodol. 2018 Sep 12;18(1):93
pubmed: 30208858
Trans R Soc Trop Med Hyg. 2013 Jan;107(1):8-14
pubmed: 23222943
Malar J. 2018 Jan 18;17(1):39
pubmed: 29347953
Malar J. 2017 Nov 7;16(1):448
pubmed: 29115954
Malar J. 2018 Nov 6;17(1):412
pubmed: 30400885
Emerg Infect Dis. 2007 Feb;13(2):199-206
pubmed: 17479880
BMC Public Health. 2013 Aug 14;13:751
pubmed: 23941585
PLoS One. 2015 Dec 16;10(12):e0145207
pubmed: 26674643

Auteurs

Gillon Ilombe (G)

Unit of Entomology, Department of Parasitology, National Institute of Biomedical Research, Kinshasa, Democratic Republic of the Congo. gillonilombe@yahoo.fr.
Unit of Clinical Pharmacology and Pharmacovigilance, Department of Base Science, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo. gillonilombe@yahoo.fr.
Global Health Institute, Antwerp University, Antwerp, Belgium. gillonilombe@yahoo.fr.

Junior Rika Matangila (JR)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Aimee Lulebo (A)

Faculty of Medicine, Public Health School, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Paulin Mutombo (P)

Faculty of Medicine, Public Health School, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Sylvie Linsuke (S)

Global Health Institute, Antwerp University, Antwerp, Belgium.
Department of Epidemiology Kinshasa, National Institute of Biomedical Research, Kinshasa, Democratic Republic of the Congo.

Vivi Maketa (V)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Baby Mabanzila (B)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Francis Wat'senga (F)

Unit of Entomology, Department of Parasitology, National Institute of Biomedical Research, Kinshasa, Democratic Republic of the Congo.

Wim Van Bortel (W)

Unit of Entomology and Outbreak Research Team, Unit of Entomology, Institute of Tropical Medicine, Antwerp, Belgium.

Agossa Fiacre (A)

PMI VectorLink Project, Abt Associates, Kinshasa, Democratic Republic of the Congo.

Seth R Irish (SR)

Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, President's Malaria Initiative and Entomology Branch, Atlanta, GA, USA.

Pascal Lutumba (P)

Department of Tropical Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.

Jean-Pierre Van Geertruyden (JP)

Global Health Institute, Antwerp University, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH